Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Raskob, Gary
Item TypeName
Concept Risk
Concept Risk Factors
Concept Risk Assessment
Academic Article Hemorrhagic complications of anticoagulant treatment.
Academic Article Chemical (VX) terrorist threat: public knowledge, attitudes, and responses.
Academic Article Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
Academic Article The design and implementation of a new surveillance system for venous thromboembolism using combined active and passive methods.
Academic Article Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.
Academic Article Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists.
Academic Article Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
Academic Article Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials.
Academic Article Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A U.S. Perspective.
Academic Article Hemorrhagic complications of anticoagulant treatment.
Academic Article Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.
Academic Article Hemorrhagic complications of long-term anticoagulant therapy.
Academic Article A new noninvasive management strategy for patients with suspected pulmonary embolism.
Academic Article Effect of treatment with low-dose warfarin-aspirin on activated factor VII.
Academic Article Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement.
Academic Article Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery.
Academic Article The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.
Academic Article Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
Academic Article Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials.
Academic Article Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups.
Academic Article Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.
Academic Article Global public awareness of venous thromboembolism.
Academic Article Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.
Academic Article The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.
Academic Article Global public awareness of venous thromboembolism: reply.
Academic Article Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension.
Academic Article New paradigms in venous thromboprophylaxis of medically ill patients.
Academic Article Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study.
Academic Article Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study.
Academic Article Incidence of Venous Thromboembolism in a Racially Diverse Population of Oklahoma County, Oklahoma.
Academic Article Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.
Academic Article Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Consideration of noninvasive management.
Academic Article Aging and heparin-related bleeding.
Academic Article Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.
Academic Article Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Academic Article Prevention of central venous catheter-associated thrombosis: a meta-analysis.
Academic Article American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
Academic Article Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.
Academic Article Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Academic Article Epidemiology and pathogenesis of venous thrombosis.
Academic Article RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate.
Academic Article Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.
Academic Article Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended Thromboprophylaxis.
Academic Article Underuse of venous thromboembolism prophylaxis for general surgery patients: physician practices in the community hospital setting.
Academic Article Hemorrhagic complications of anticoagulant treatment.
Academic Article Withholding treatment in patients with acute pulmonary embolism who have a high risk of bleeding and negative serial noninvasive leg tests.
Academic Article Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.
Academic Article Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop.
Academic Article A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery.
Academic Article The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs.
Academic Article Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy. A sub-analysis of the AMPLIFY trial.
Academic Article Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists.
Academic Article Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysis.
Academic Article The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients.
Academic Article The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations.
Academic Article Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial.
Academic Article Prophylaxis of venous thromboembolism. An overview.
Academic Article Risk of haemorrhage associated with long term anticoagulant therapy.
Academic Article Hemorrhagic complications of anticoagulant treatment.
Academic Article Long-term oral anticoagulant therapy for coronary artery disease.
Academic Article Duration of anticoagulant treatment for venous thrombosis.
Grant THROMBOSIS: ETIOLOGY, RISK FACTORS AND TREATMENT
Grant OU Developmental Center for Injury Prevention Research
Academic Article Benefit-Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER.
Academic Article Abelacimab for Prevention of Venous Thromboembolism. Reply.
Academic Article Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older.
Academic Article Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis.
Academic Article Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban.
Academic Article Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis.
Academic Article Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
Academic Article Cancer-associated venous thromboembolism: Incidence and features in a racially diverse population.
Academic Article Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score.
Academic Article Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness.
Search Criteria
  • Risk